Mozz, so what we are really saying is there is relatively little risk in both the phase 3 trial or the IP and the main risks lie with the regulatory approvals of the various countries Paradigm wishes to sell the drug.
Mozz, so what we are really saying is there is relatively little...
-
- There are more pages in this discussion • 4,090 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
-0.010(4.76%) |
Mkt cap ! $70.04M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 22.0¢ | 20.0¢ | $221.1K | 1.062M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 324368 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 10349 | 1 |
View Market Depth
| Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |